Invivyd Announces Positive Phase 1/2 Clinical Data for VYD2311
Invivyd announced positive Phase 1/2 clinical trial data for VYD2311, its next-generation monoclonal antibody designed to prevent and treat...
Altimmune Announces Positive Topline Results for Pemvidutide
Altimmune, Inc. announced positive topline results from its Phase 2b IMPACT trial of pemvidutide for metabolic dysfunction-associated steatohepatitis (MASH)....
CRISPR Therapeutics Reports Positive Phase 1 Data for CTX310™
CRISPR Therapeutics announced updates on its in vivo cardiovascular disease programs, including new Phase 1 data for CTX310 targeting...
Pliant Therapeutics Announces Positive Update on Phase 2a Beacon-IPF Study
Pliant Therapeutics has halted the development of bexotegrast for idiopathic pulmonary fibrosis (IPF) after a Phase 2b/3 trial, BEACON-IPF,...
HCW Biologics: IND-Enabling T-Cell Engager Updates & Preclinical Success
HCW Biologics has developed second-generation, multi-specific T-cell engagers targeting solid tumors, particularly pancreatic cancer, using its proprietary TRBC platform....
Tango Tx Doses First Patient in TNG462 Phase 1/2 Trial
Tango Therapeutics has initiated a Phase 1/2 trial evaluating TNG462, a PRMT5 inhibitor, in combination with Revolution Medicines’ RAS...
GlucoTrack’s Continuous Glucose Monitor Shows Positive Results in Human Study
Glucotrack, Inc. announced positive results from its first-in-human clinical study of its implantable continuous blood glucose monitor (CBGM). The...
Amneal’s Biosimilar Candidate Positive Topline Results
Amneal Pharmaceuticals announced positive topline results from a Phase 3 trial of ADL-018, a biosimilar to XOLAIR® (omalizumab), developed...
Assembly Biosciences Reports Positive Topline Results From Phase 1b Trial of Next-Gen Capsid Assembly Modulator ABI-4334
Assembly Biosciences announced positive topline results from a Phase 1b study of ABI-4334, a next-generation capsid assembly modulator (CAM),...
Soquelitinib IND Approved for Atopic Dermatitis Trial in China
Corvus Pharmaceuticals‘ partner in China, Angel Pharma, has received approval from the China National Medical Products Administration (NMPA) to...